HTL Biotechnology
Marie-armelle Floc'h currently serves as the Chief Quality and Compliance Officer at HTL Biotechnology, where responsibilities include overseeing Quality Assurance, Quality Control, and Regulatory Compliance. Previously, Marie-armelle held the position of Quality Director at HTL Biotechnology, focusing on regulatory standards and site conformance. Prior experience includes serving as Senior Quality Manager at GSK, managing a team of four managers and overseeing key quality processes. Marie-armelle's career began at GSK as a Quality Control Assistant and later included roles such as Quality Control Manager and Project Management Leader at CEVA SANTE ANIMALE, where skills in laboratory management and IT system compliance were developed. Marie-armelle holds a master’s degree in quality assurance and chemistry from Faculté des sciences de Nantes.
This person is not in any offices
HTL Biotechnology
HTL is the world leader in the development and production of pharmaceutical grade biopolymers used to develop life-changing treatments for millions of patients. A pioneer in the bioproduction of hyaluronic acid, HTL has developed and refined for over 30 years its innovative functional biopolymer platform that has enabled it to produce "customised" pharmaceutical grade products for the leaders of the pharmaceutical and medical devices sectors in therapeutic areas such as ophthalmology, dermatology, medical aesthetics, rheumatology and urology Thanks to its dedicated R&D team, its partnerships and its incubator, HTL is now driving innovation in the biopolymer sector. Its R&D strategy aims to address unmet medical needs by creating new types of biopolymers, modifying their physico-chemical properties, and exploring new medical applications in cutting-edge areas such as bioprinting and drug delivery. very.